Is metformin a therapeutic paradigm for colorectal cancer: Insight into the molecular pathway?
Colorectal cancer (CRC) remains one of the major leading causes of cancer related morbidity and mortality. Apart from the conventional anti-neoplastic agents, metformin, a biguanide anti-diabetic agent, has recently found to have anti-cancer property. Several studies observed the effect of metformin...
| Published in: | Current Drug Targets |
|---|---|
| Main Author: | |
| Format: | Review |
| Language: | English |
| Published: |
Bentham Science Publishers B.V.
2017
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019587803&doi=10.2174%2f1389450118666161205125548&partnerID=40&md5=6a171daf9f53a3276a14e415d6366131 |